Next, we compared the tumor infiltration levels among PAAD with different somatic copy number alterations for each CXC chemokine and found that the somatic copy number alterations for the CXC chemokines can inhibit CD4+ T cell infiltration (Figure S6). This evidence concerns the gene CD4 and pancreatic adenocarcinoma.